These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
243 related items for PubMed ID: 9309760
21. Communicating Antitachycardia Pacing-Enabled Leadless Pacemaker and Subcutaneous Implantable Defibrillator. Tjong FVY, Brouwer TF, Kooiman KM, Smeding L, Koop B, Soltis B, Shuros A, Wilde AAM, Burke M, Knops RE. J Am Coll Cardiol; 2016 Apr 19; 67(15):1865-1866. PubMed ID: 27012782 [No Abstract] [Full Text] [Related]
23. Treatment of the bradycardia-tachycardia syndrome with permanent demand pacing. Pittman DE. Angiology; 1976 Apr 24; 27(4):243-54. PubMed ID: 1053530 [Abstract] [Full Text] [Related]
24. Eligibility of Pacemaker Patients for Subcutaneous Implantable Cardioverter Defibrillators. Ip JE, Wu MS, Kennel PJ, Thomas G, Liu CF, Cheung JW, Markowitz SM, Lerman BB. J Cardiovasc Electrophysiol; 2017 May 24; 28(5):544-548. PubMed ID: 28185354 [Abstract] [Full Text] [Related]
25. [Combined therapy with transvenous cardioverter/defibrillator and anti-bradycardia pacemaker systems]. Sticherling C, Klingenheben T, Skupin M, Li YG, Hohnloser SH. Z Kardiol; 1997 Feb 24; 86(2):105-12. PubMed ID: 9173694 [Abstract] [Full Text] [Related]
27. AAIR versus DDDR pacing in the bradycardia tachycardia syndrome: a prospective, randomized, double-blind, crossover trial. Schwaab B, Kindermann M, Schätzer-Klotz D, Berg M, Franow H, Fröhlig G, Schieffer H. Pacing Clin Electrophysiol; 2001 Nov 24; 24(11):1585-95. PubMed ID: 11816626 [Abstract] [Full Text] [Related]
28. Interactions between transvenous nonthoracotomy cardioverter defibrillator systems and permanent transvenous endocardial pacemakers. Geiger MJ, O'Neill P, Sharma A, Skadsen A, Zimerman L, Greenfield RA, Newby KH, Wharton JM, Kent V, Natale A. Pacing Clin Electrophysiol; 1997 Mar 24; 20(3 Pt 1):624-30. PubMed ID: 9080488 [Abstract] [Full Text] [Related]
29. The DAVID (Dual Chamber and VVI Implantable Defibrillator) II trial. Wilkoff BL, Kudenchuk PJ, Buxton AE, Sharma A, Cook JR, Bhandari AK, Biehl M, Tomassoni G, Leonen A, Klevan LR, Hallstrom AP, DAVID II Investigators. J Am Coll Cardiol; 2009 Mar 10; 53(10):872-80. PubMed ID: 19264245 [Abstract] [Full Text] [Related]
30. Cardiac device therapy 1: theory, technology and terminology. Modi S, Rao A, Hughes S, Ramsdale D. Br J Hosp Med (Lond); 2008 Nov 10; 69(11):620-4. PubMed ID: 19069261 [Abstract] [Full Text] [Related]
31. Oversensing during ventricular pacing in patients with a third-generation implantable cardioverter-defibrillator. Kelly PA, Mann DE, Damle RS, Reiter MJ. J Am Coll Cardiol; 1994 Jun 10; 23(7):1531-4. PubMed ID: 8195509 [Abstract] [Full Text] [Related]
32. Long-term endocardial atrial pacing in children with postoperative bradycardia-tachycardia syndrome and limited ventricular access. McGoon MD, Maloney JD, McGoon DC, Danielson GK. Am J Cardiol; 1982 May 10; 49(7):1750-7. PubMed ID: 7081061 [Abstract] [Full Text] [Related]